AngioDynamics Awarded $74.9 Million in Case Against biolitec AG
20 mars 2014 06h30 HE
|
AngioDynamics
ALBANY, N.Y., March 20, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Receives Expanded FDA Clearance for AngioVac
11 mars 2014 06h30 HE
|
AngioDynamics
ALBANY, N.Y., March 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Receives FDA Clearance for DuraMax Dialysis Catheter With BioFlo Technology to Reduce Catheter-Related Thrombus
07 mars 2014 06h30 HE
|
AngioDynamics
ALBANY, N.Y., March 7, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Updates U.S. Tip Location Strategy
06 mars 2014 16h01 HE
|
AngioDynamics
ALBANY, N.Y., March 6, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Present at the Barclays Global Healthcare Conference
03 mars 2014 07h00 HE
|
AngioDynamics
ALBANY, N.Y., March 3, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Reports Fiscal 2014 Second Quarter Financial Results
09 janv. 2014 16h01 HE
|
AngioDynamics
Net sales of $88.6 million
GAAP income per share at break-even; Non-GAAP adjusted net income, excluding amortization, of $0.14 per share
Adjusted EBITDA of $12.7 million
Operating...
AngioDynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference
18 déc. 2013 07h00 HE
|
AngioDynamics
ALBANY, N.Y., Dec. 18, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Report Fiscal 2014 Second Quarter Financial Results
12 déc. 2013 07h00 HE
|
AngioDynamics
ALBANY, N.Y., Dec. 12, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Appoints John Soto Chief Commercial Officer
11 déc. 2013 07h00 HE
|
AngioDynamics
ALBANY, N.Y., Dec. 11, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Comments on New Reimbursement Rate for Hospital-Based Varicose Vein Ablations
10 déc. 2013 07h00 HE
|
AngioDynamics
ALBANY, N.Y., Dec. 10, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...